The Nov. 30 release of data from a transcatheter aortic valve replacement (TAVR) registry provided clinicians, patients and payers with robust, real world information on a procedure that’s becoming more popular.

Patients who underwent transcatheter aortic valve replacement (TAVR) in the U.S. from 2012 to 2014 tended to be at least 80 years old and have multiple comorbidities, a high predicted risk of mortality and a poor self-reported health status, according to a registry analysis.

Hear what’s new from Meril's vice president, Sanjeev Bhatt, on tapered drug eluting stents, bioabsorbable scaffolds, dilatation catheters and TAVR.

Boston Scientific recalled its RotaWire Elite Guidewires and wireClip Torquer Guidewires after receiving three reports of the wires cracking and separating from the Rotablator Rotational Atherectomy System.

After one year, patients with long coronary lesions who were implanted with an intravascular ultrasound-guided everolimus-eluting stent had a significantly lower rate of major adverse cardiac events compared with those implanted with an angiography-guided stent.

Medtronic announced on Nov. 18 it had acquired Aircraft Medical, a company that develops video laryngoscopes that anesthesiologists and critical care professionals use to intubate patients.

The long-term risk of stroke after patients underwent CABG was significantly higher in patients with type 1 or type 2 diabetes compared with those who did not have diabetes, according to an analysis from Swedish researchers.

For patients undergoing transcatheter atrial septal defect (ASD) closure, the use of dual antiplatelet therapy consisting of clopidogrel and aspirin led to fewer migraine headaches and less severe migraine episodes compared with taking aspirin alone, according to a randomized, double-blind trial.